TrialClinical genitourinary cancer2015

Atrasentan in Patients With Advanced Renal Cell Carcinoma: A Phase 2 Trial of the ECOG-ACRIN Cancer Research Group (E6800).

Michael A Carducci et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.